The Evan Bray Show - Matthew Kaeberlein - October 15th, 2024

Loading player...
A drug typically prescribed to suppress the immune systems of organ transplant patients is being used by everyday people, now, with the hope of delaying aging and age-related diseases. Dr. Matthew Kaeberlein, CEO of Optispan, an American healthcare technology company, joins Evan to discuss the hype around rapamycin.
15 Oct 2024 1PM English Canada News Commentary

Other recent episodes

No experience, no job: The youth employment struggle

A new report from the Fraser Institute shows us young people are struggling to find work right now, even though the overall economy is still growing, albeit slowly. Entry-level jobs are more competitive than usual, leaving many youth squeezed out of the labour market. Philip Cross, Senior Fellow, Fraser Institute,…
1 May 1PM 16 min

The $25B question: Investment or debt disaster?

Earlier this week, the feds announced the sovereign wealth fund. The conservatives, including Andrew Scheer, member of Parliament for Regina—Qu'Appelle, former Conservative Party leader and former Speaker of the House, are calling this the "debt fund." Scheer joins the show to share why he thinks Canadians would be better off…
1 May 11AM 16 min